Condensed Consolidated Interim Financial Statements as of June 30, 2018

Bayer Group
Consolidated Statements of Changes in Equity

 

 

Capital stock

 

Capital reserves

 

Other reserves

 

Equity attributable to Bayer AG stockholders

 

Equity attributable to non-controlling interest

 

Equity

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Dec. 31, 2016

 

2,117

 

9,658

 

18,558

 

30,333

 

1,564

 

31,897

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

(2,233)

 

(2,233)

 

(129)

 

(2,362)

Other changes

 

 

 

 

 

1,993

 

1,993

 

1,020

 

3,013

Total comprehensive income

 

 

 

 

 

2,557

 

2,557

 

378

 

2,935

June 30, 2017

 

2,117

 

9,658

 

20,875

 

32,650

 

2,833

 

35,483

Dec. 31, 2017

 

2,117

 

9,658

 

25,026

 

36,801

 

60

 

36,861

Adjustment of retained earnings on adoption of IFRS 9 (net of tax)

 

 

 

 

 

(60)

 

(60)

 

 

 

(60)

Adjustment of retained earnings on adoption of IFRS 15 (net of tax)

 

 

 

 

 

86

 

86

 

 

 

86

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

270

 

8,730

 

 

 

9,000

 

 

 

9,000

Dividend payments

 

 

 

 

 

(2,402)

 

(2,402)

 

 

 

(2,402)

Other changes

 

 

 

 

 

(5)

 

(5)

 

12

 

7

Total comprehensive income

 

 

 

 

 

3,726

 

3,726

 

1

 

3,727

June 30, 2018

 

2,387

 

18,388

 

26,371

 

47,146

 

73

 

47,219

Compare to Last Year